{"id":18812,"date":"2022-03-04T08:21:49","date_gmt":"2022-03-04T16:21:49","guid":{"rendered":"https:\/\/marketdepth.com\/?p=18812"},"modified":"2022-03-04T08:21:51","modified_gmt":"2022-03-04T16:21:51","slug":"statera-biopharma-submits-pilot-study-to-u-s-fda","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/","title":{"rendered":"Statera Biopharma Submits Pilot Study to U.S. FDA"},"content":{"rendered":"\n<p><strong>Statera Biopharma, Inc. (Nasdaq: STAB)<\/strong> recently <a href=\"https:\/\/finance.yahoo.com\/news\/correction-statera-biopharma-submits-phase-140800840.html\">announced <\/a>that it submitted a pilot study protocol for STAT-205 treatment of post-acute COVID-19 to the U.S. Food and Drug Administration (FDA).<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Pilot Program<\/h5>\n\n\n\n<p>The Phase 1 pilot study is set to evaluate the Safety and Efficacy of STAT-205 in approximately 84 patients with Post-acute Sequalae of SARS-CoV-2 infection (PASC). Additionally, STAT-205 for acute COVID is currently being evaluated in Phase 1 clinical trial in adult patients with mild COVID-19 who are at high risk of disease progression.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-style-large\"><p>\u201cSubmitting this study protocol to the FDA is a critical milestone in the development of our COVID-19 program. As the world continues to struggle with the COVID-19 pandemic, post-acute COVID syndrome remains a widespread, often debilitating condition that is not well understood. With STAT-205 Statera looks to potentially offer a promising treatment approach to those patients facing the long-lasting burden of the illness.\u201d<\/p><cite>Michael K. Handley, President and Chief Executive Officer, Statera Biopharma<\/cite><\/blockquote>\n\n\n\n<p>Persistent fatigue following COVID-19 is one of the most common symptoms, and no standard of care for PASC exists.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"Statera Biopharma, Inc. (Nasdaq: STAB) recently announced that it submitted a pilot study protocol for STAT-205 treatment of post-acute COVID-19 to the U.S. Food and Drug Administration (FDA). Pilot Program The Phase 1 pilot study is set to evaluate the Safety and Efficacy of STAT-205 in approximately 84 patients with Post-acute Sequalae of SARS-CoV-2 infection&#8230; <a class=\"view-article\" href=\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\">View Article<\/a>","protected":false},"author":3,"featured_media":18372,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[9,31,17,8,11,16],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Statera Biopharma Submits Pilot Study to U.S. FDA - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Statera Biopharma Submits Pilot Study to U.S. FDA - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"Statera Biopharma, Inc. (Nasdaq: STAB) recently announced that it submitted a pilot study protocol for STAT-205 treatment of post-acute COVID-19 to the U.S. Food and Drug Administration (FDA). Pilot Program The Phase 1 pilot study is set to evaluate the Safety and Efficacy of STAT-205 in approximately 84 patients with Post-acute Sequalae of SARS-CoV-2 infection... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-04T16:21:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-04T16:21:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2022\/01\/Test-Tube-Liquid-Inject.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"Statera Biopharma Submits Pilot Study to U.S. FDA\",\"datePublished\":\"2022-03-04T16:21:49+00:00\",\"dateModified\":\"2022-03-04T16:21:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\"},\"wordCount\":184,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Biotechnology\",\"Business\",\"Headlines\",\"Healthcare\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\",\"url\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\",\"name\":\"Statera Biopharma Submits Pilot Study to U.S. FDA - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2022-03-04T16:21:49+00:00\",\"dateModified\":\"2022-03-04T16:21:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Statera Biopharma Submits Pilot Study to U.S. FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News &amp; Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Statera Biopharma Submits Pilot Study to U.S. FDA - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/","og_locale":"en_US","og_type":"article","og_title":"Statera Biopharma Submits Pilot Study to U.S. FDA - MarketDepth","og_description":"Statera Biopharma, Inc. (Nasdaq: STAB) recently announced that it submitted a pilot study protocol for STAT-205 treatment of post-acute COVID-19 to the U.S. Food and Drug Administration (FDA). Pilot Program The Phase 1 pilot study is set to evaluate the Safety and Efficacy of STAT-205 in approximately 84 patients with Post-acute Sequalae of SARS-CoV-2 infection... View Article","og_url":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2022-03-04T16:21:49+00:00","article_modified_time":"2022-03-04T16:21:51+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2022\/01\/Test-Tube-Liquid-Inject.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"Statera Biopharma Submits Pilot Study to U.S. FDA","datePublished":"2022-03-04T16:21:49+00:00","dateModified":"2022-03-04T16:21:51+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/"},"wordCount":184,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Biotechnology","Business","Headlines","Healthcare","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/","url":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/","name":"Statera Biopharma Submits Pilot Study to U.S. FDA - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2022-03-04T16:21:49+00:00","dateModified":"2022-03-04T16:21:51+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/statera-biopharma-submits-pilot-study-to-u-s-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"Statera Biopharma Submits Pilot Study to U.S. FDA"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News &amp; Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18812"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=18812"}],"version-history":[{"count":1,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18812\/revisions"}],"predecessor-version":[{"id":18813,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18812\/revisions\/18813"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/18372"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=18812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=18812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=18812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}